SCHEMBL8970658

SCHEMBL8970658

COc1cccc2c1CC(CNCCCCN1C(=O)N(c3ccccc3)c3ccccc3S1(O)O)CC2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.39
MTNR1B P49286 3/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
DRD2 P14416 4/20 0.39
HTR1A P08908 3/20 0.39
DRD1 P21728 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
DRD3 P35462 2/20 0.37
ADRA1A P35348 1/20 0.37
DRD4 P21917 2/20 0.36
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
DRD5 P21918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8970653 0.92 HTR1A (0.41) MTNR1AMTNR1BCHRM2CHRM1CHRM3
SCHEMBL8996726 0.84 HTR1A (0.49) MTNR1AMTNR1BCHRM2CHRM1CHRM3
SCHEMBL8971218 0.79 HTR1A (0.59) DRD2HTR1AHTR2ADRD3DRD4
SCHEMBL9382677 0.78 ADRA1D (0.42) MTNR1AMTNR1BCHRM2CHRM1CHRM3
SCHEMBL8969531 0.78 HTR7 (0.55) CHRM2CHRM1CHRM3DRD2HTR1A
SCHEMBL9382674 0.77 CHRM2 (0.45) MTNR1AMTNR1BCHRM2CHRM1CHRM3
SCHEMBL9471280 0.72 DRD2 (0.42) CHRM2CHRM3DRD2HTR1AHTR2A
SCHEMBL9286203 0.72 HTR1A (0.54) DRD2HTR1AHTR2ADRD3DRD4
SCHEMBL8970407 0.71 SIGMAR1 (0.53) MTNR1AMTNR1BCHRM2CHRM1CHRM3
SCHEMBL9471075 0.71 HTR1A (0.41) CHRM2CHRM3DRD2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed
EP-0352613-A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1990-01-31 EP disclosed